Theravance Biopharma to Participate in Upcoming Investor Conferences
DUBLIN, Nov. 19, 2025 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that management will participate in…
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
Ampreloxetine clinical development program to be featured in four presentations at the upcoming International Symposium on The Autonomic…